Cargando…

Prediction of outcomes after second-line treatment for acute graft-versus-host disease

Acute graft-versus-host disease (GVHD) requiring second-line treatment represents a highly morbid complication of allogenic hematopoietic cell transplantation (HCT). Recent studies have defined short-term outcomes after second-line treatment for acute GVHD, but longer-term outcomes have not been wel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vo, Phuong, Gooley, Ted A., Carpenter, Paul A., Sorror, Mohamed L., MacMillan, Margaret L., DeFor, Todd E., Martin, Paul J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198915/ https://www.ncbi.nlm.nih.gov/pubmed/35235948 http://dx.doi.org/10.1182/bloodadvances.2021006220

Ejemplares similares

Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival
por: Pidala, Joseph, et al.
Publicado: (2021)

Validation of Minnesota acute graft-versus-host disease Risk Score
por: MacMillan, Margaret L., et al.
Publicado: (2020)

MicroRNA serum profiles and chronic graft-versus-host disease
por: Reikvam, Håkon, et al.
Publicado: (2022)

Genetic variants associated with inflammatory bowel disease and gut graft-versus-host disease
por: Martin, Paul J., et al.
Publicado: (2021)

Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
por: Cutler, Corey, et al.
Publicado: (2021)

EASIX-1year and late mortality after allogeneic stem cell transplantation
por: Kordelas, Lambros, et al.
Publicado: (2023)

Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease
por: Akahoshi, Yu, et al.
Publicado: (2022)

Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
por: Herzog, Shannon, et al.
Publicado: (2023)

High cutaneous amphiregulin expression predicts fatal acute graft‐versus‐host disease
por: Schultz, Brittney, et al.
Publicado: (2022)

A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study
por: Cuvelier, Geoffrey D. E., et al.
Publicado: (2022)

Evidence-based, Skin-directed Treatments for Cutaneous Chronic Graft-versus-host Disease
por: Kim, Yoo Jung, et al.
Publicado: (2019)

Prospective external validation of biomarkers to predict acute graft-versus-host disease severity
por: Robin, Marie, et al.
Publicado: (2022)

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease
por: Pratta, Michael, et al.
Publicado: (2022)

Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease
por: Shrestha, Pradeep, et al.
Publicado: (2023)

Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression
por: Zhu, Jingru, et al.
Publicado: (2022)

The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease
por: Pang, Yifan, et al.
Publicado: (2022)

Organ-specific response after low-dose interleukin-2 therapy for steroid-refractory chronic graft-versus-host disease
por: Kim, Haesook T., et al.
Publicado: (2022)

Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: SARS-CoV-2 Vaccine as a Potential Trigger
por: Azem, Amin, et al.
Publicado: (2022)

Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis
por: Socié, Gerard, et al.
Publicado: (2023)

Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation
por: Ueda Oshima, Masumi, et al.
Publicado: (2023)

Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis
por: Roy, Denis Claude, et al.
Publicado: (2019)

Clinical Outcomes Using Mycophenolate and Tacrolimus for Graft-versus-Host Disease Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplant: A Single Institution Experience
por: Hashmi, Hamza, et al.
Publicado: (2020)

Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation
por: Petersdorf, Effie W., et al.
Publicado: (2023)

The role of extracorporeal photopheresis in the management of cutaneous T‐cell lymphoma, graft‐versus‐host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society
por: Alfred, Arun, et al.
Publicado: (2017)

Graft Versus Host Disease After Intestinal Transplantation: A Single-center Experience
por: Kaufman, Stuart S., et al.
Publicado: (2021)

T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity
por: Lum, Su Han, et al.
Publicado: (2022)

Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation
por: Hough, Rachael, et al.
Publicado: (2022)

Clonal expansion of CD8(+) T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI
por: Schultze-Florey, Christian R., et al.
Publicado: (2021)

Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant
por: Wu, Natalie L., et al.
Publicado: (2022)

Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium
por: DeFilipp, Zachariah, et al.
Publicado: (2021)

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
por: Maurer, Katie, et al.
Publicado: (2021)

Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
por: Ragon, Brittany Knick, et al.
Publicado: (2023)

Megadose (90)Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma
por: Chow, Victor A., et al.
Publicado: (2021)

How Resiliency Affects Quality of Life Twenty-two Years Post-cardiac Transplant: a Case Report
por: Vo, Joslyn, et al.
Publicado: (2017)

Pancreatic Grafts from Pediatric Donors Do Not Appear to Grow After Transplantation into Adults
por: Christensen, Kaerli, et al.
Publicado: (2018)

Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure
por: Sabulski, Anthony, et al.
Publicado: (2021)

Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
por: Arslan Davulcu, Eren, et al.
Publicado: (2023)

Local Autoantigen Expression as Essential Gatekeeper of Memory T-Cell Recruitment to Islet Grafts in Diabetic Hosts
por: Alkemade, Gonnie M., et al.
Publicado: (2013)

Genetic susceptibility to delayed graft function following kidney transplantation: a systematic review of the literature
por: Huart, Justine, et al.
Publicado: (2018)

Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic
por: Devine, Steven M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e8rhpd6fr5op0kfhuhne0ohh1o